help button home button Endocrine Society JCEM ENDO 08
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barker, J. M.
Right arrow Articles by Rewers, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, J. M.
Right arrow Articles by Rewers, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 8 3896-3902
Copyright © 2004 by The Endocrine Society

Prediction of Autoantibody Positivity and Progression to Type 1 Diabetes: Diabetes Autoimmunity Study in the Young (DAISY)

Jennifer M. Barker, Katherine J. Barriga, Liping Yu, Dongmei Miao, Henry A. Erlich, Jill M. Norris, George S. Eisenbarth and Marian Rewers

Barbara Davis Center for Childhood Diabetes (J.M.B., L.Y., D.M., G.S.E., M.R.) and Department of Preventive Medicine and Biometrics (K.J.B., J.M.N.), University of Colorado Health Sciences Center, Denver, Colorado 80262; and Department of Human Genetics (H.A.E.), Roche Molecular Systems, Inc., Alameda, California 94501

Address all correspondence and requests for reprints to: Jennifer M. Barker, M.D., 4200 East 9th Avenue, Box B-140, Denver, Colorado 80262. E-mail: jennifer.barker{at}uchsc.edu.

Diabetes Autoimmunity Study in the Young (DAISY) has followed 1972 children for islet autoimmunity and diabetes: 837 first-degree relatives of persons with type 1 diabetes and 1135 general population newborns identified through human leukocyte antigen (HLA) screening. During follow-up of 4.06 yr (range, 0.17–9 yr), serial determination of autoantibodies to glutamic acid decarboxylase, protein tyrosine phosphatase IA2, and insulin has generated approximately 20,000 results. Among 162 children with at least one positive autoantibody, in 31% the test was false positive (autoantibodies were negative twice on blinded duplicate aliquots), in 31% it was transiently positive (confirmed on blinded duplicate aliquots but negative on follow-up), and in 36% it was persistently positive. Using proportional hazards modeling, the HLA-DR3/4 DQ8 genotype, another positive autoantibody at the first positive visit, and level of autoantibody were predictive of persistent positivity. Only HLA-DR3/4 DQ8 genotype was predictive of progression to diabetes in proportional hazards modeling. This prospective study reveals that cross-sectional determination of islet autoantibodies in a population with relatively low previous probability of autoimmunity identifies as "positive" a large number of individuals who are either false or transiently positive. Predictive value of autoantibodies increases with blinded duplicate and independent sample retesting and incorporation of the level of autoantibody in the predictive algorithm.

This work was supported by National Institutes of Health Grants DK 32083, DK 32493, DK 57516, AI 39213, AI 50864, and S-M01-RR00051. J.M.B. was supported by a fellowship grant from the Juvenile Diabetes Research Foundation (13-2002-444).

Abbreviations: GAA, Antibodies to glutamic acid decarboxylase; HLA, human leukocyte antigen; IA-2AA, antibodies to protein tyrosine phosphatase IA2; IAA, antibodies to insulin; ICA, islet cell autoantibodies; PPV, positive predictive value; T1DM, type 1 diabetes mellitus.




This article has been cited by other articles:


Home page
DiabetesHome page
A. K. Steck and G. S. Eisenbarth
Genetic Similarities Between Latent Autoimmune Diabetes and Type 1 and Type 2 Diabetes
Diabetes, May 1, 2008; 57(5): 1160 - 1162.
[Full Text] [PDF]


Home page
DiabetesHome page
T. A. Aly, E. E. Baschal, M. M. Jahromi, M. S. Fernando, S. R. Babu, T. E. Fingerlin, A. Kretowski, H. A. Erlich, P. R. Fain, M. J. Rewers, et al.
Analysis of Single Nucleotide Polymorphisms Identifies Major Type 1A Diabetes Locus Telomeric of the Major Histocompatibility Complex
Diabetes, March 1, 2008; 57(3): 770 - 776.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. E. Baschal, T. A. Aly, S. R. Babu, M. S. Fernando, L. Yu, D. Miao, K. J. Barriga, J. M. Norris, J. A. Noble, H. A. Erlich, et al.
HLA-DPB1*0402 Protects Against Type 1A Diabetes Autoimmunity in the Highest Risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY Population
Diabetes, September 1, 2007; 56(9): 2405 - 2409.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. F. Green
Summary of Workgroup Meeting on Use of Family History Information in Pediatric Primary Care and Public Health
Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S87 - S100.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N. R. ROSE
Prediction and Prevention of Autoimmune Disease: A Personal Perspective
Ann. N.Y. Acad. Sci., August 1, 2007; 1109(1): 117 - 128.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Aly, A. Ide, M. M. Jahromi, J. M. Barker, M. S. Fernando, S. R. Babu, L. Yu, D. Miao, H. A. Erlich, P. R. Fain, et al.
Extreme genetic risk for type 1A diabetes
PNAS, September 19, 2006; 103(38): 14074 - 14079.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. A. Deeg, D. Pompetzki, A. J. Raith, S. M. Hauck, B. Amann, S. Suppmann, T. W. F. Goebel, U. Olazabal, H. Gerhards, S. Reese, et al.
Identification and Functional Validation of Novel Autoantigens in Equine Uveitis
Mol. Cell. Proteomics, August 1, 2006; 5(8): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. D. G. Leslie, R. Williams, and P. Pozzilli
Type 1 Diabetes and Latent Autoimmune Diabetes in Adults: One End of the Rainbow
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1654 - 1659.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Larizza, V. Calcaterra, M. Martinetti, R. Negrini, A. De Silvestri, M. Cisternino, A. M. Iannone, and E. Solcia
Helicobacter pylori Infection and Autoimmune Thyroid Disease in Young Patients: The Disadvantage of Carrying the Human Leukocyte Antigen-DRB1*0301 Allele
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 176 - 179.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Achenbach, E. Bonifacio, K. Koczwara, and A.-G. Ziegler
Natural History of Type 1 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S25 - S31.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. J. Woodward and J. W. Thomas
Multiple Germline {kappa} Light Chains Generate Anti-Insulin B Cells in Nonobese Diabetic Mice
J. Immunol., July 15, 2005; 175(2): 1073 - 1079.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N. BABAYA, M. NAKAYAMA, and G. S. EISENBARTH
The Stages of Type 1A Diabetes
Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 194 - 204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society